Question 1

How does Clew's AI technology improve patient outcomes in critical care settings?

Accepted Answer

Clew uses FDA-cleared AI-based predictive analytics to identify patient deterioration risks up to eight hours before traditional monitoring systems. By providing highly accurate early warnings, Clew enables clinicians to intervene proactively, reducing mortality rates, complications, and readmissions. Its real-time analytics streamline critical care workflows and improve both clinical and operational outcomes, such as capacity management and length of stay.

Question 2

What measures does Clew take to ensure compliance with healthcare regulations and data privacy laws?

Accepted Answer

Clew integrates regulatory compliance from the start by adhering to FDA requirements for medical AI devices and maintaining HIPAA-compliant data handling practices. Their AI platform uses robust data governance frameworks, ensuring secure data sharing, processing, and storage. Continuous post-market surveillance, audit trails, and regulatory expertise within teams enable the effective management of evolving healthcare regulations.

Question 3

How can healthcare organizations mitigate risks related to AI bias and lack of transparency when deploying Clew's platform?

Accepted Answer

Clew emphasizes explainable AI models where clinicians can understand the rationale behind predictions to support informed decision-making. The platform advocates for regular bias audits by monitoring AI outcomes across diverse patient populations. Clew also promotes multidisciplinary AI governance committees, including clinicians and patient advocates, to guide ethical AI use while maintaining transparency and documenting clinical protocols for overriding AI recommendations.

Useful Links

Our Services

Contact Us